DIN 02456478 — RUPALL 1 MG
RUPALL is a solution of Rupatadine marketed by MEDEXUS PHARMACEUTICALS INC.. The full Rupatadine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02456478
- Brand name
- RUPALL
- Active ingredient
- Rupatadine
- Strength
- 1 MG
- Dosage form
- SOLUTION
- Route
- ORAL
- Manufacturer
- MEDEXUS PHARMACEUTICALS INC.
- Health Canada status
- MARKETED
- Drug class
- Second-generation antihistamine (H1-receptor and PAF antagonist)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Rupatadine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02553155 | APO-RUPATADINE | 10 MG | TABLET | APOTEX INC | MARKETED |
| 02552604 | PMS-RUPATADINE | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02560119 | RIVA-RUPATADINE | 10 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED |
| 02456451 | RUPALL | 10 MG | TABLET | MEDEXUS PHARMACEUTICALS INC. | MARKETED |